These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32410794)

  • 1. Clinicopathological analysis of early-stage breast cancer patients that meet indications for
    Xiang H; Xin L; Liu Q; Zhang H; Zhang S; Ye J; Cheng Y; Li T; Liu Y; Xu L
    Chin J Cancer Res; 2020 Apr; 32(2):163-174. PubMed ID: 32410794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological features and prognosis of breast cancer with human epidermal growth factor receptor 2 low expression].
    Zhu XJ; Zhang H; Zhang S; Li D; Li X; Xu L; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):243-253. PubMed ID: 37042134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An analysis of 68 invasive lobular breast cancer cases in clinicopathological characteristics and the prognostic determinants].
    Liu Q; Xiang HY; Ye JM; Xu L; Zhang H; Zhang S; Duan XN; Liu YH
    Zhonghua Wai Ke Za Zhi; 2018 Feb; 56(2):119-123. PubMed ID: 29397625
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinicopathologic analysis of 722 breast cancer patients who met the inclusion criteria of the TAILORx trial.
    Xiang HY; Liu YH; Zhang H; Zhang S; Xin L; Xu L; Ye JM; Li T; Duan XN; Liu Q
    Chin Med J (Engl); 2019 Dec; 132(24):2914-2919. PubMed ID: 31809316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the appropriate genetic testing criteria for breast cancer in the Chinese population?-Analysis of genetic and clinical features from a single cancer center database.
    Ni M; Wang F; Yang A; Shao Q; Xue C; Xia W; Xu F; Lin X; Huang J; Bi X; Hong R; Chen M; Zheng Q; Jiang K; Xie X; Tang J; Wang X; Yuan Z; Wang S; Shi Y; An X
    Cancer Med; 2023 Jun; 12(12):13019-13030. PubMed ID: 37096751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.
    Pierre ME; Manneh R; Hernández A; Rodríguez J; Fletcher AV; Ramírez HM; Niño OM; Gómez DA; Sanabria D; Contreras F; Pieschacón JR; Calderón PH
    Rev Colomb Obstet Ginecol; 2024 Jun; 75(1):. PubMed ID: 39013199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
    Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
    BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions.
    Su Y; Yao Q; Xu Y; Yu C; Zhang J; Wang Q; Li J; Shi D; Yu B; Zeng Y; Zhu X; Bai Q; Zhou X
    Front Genet; 2021; 12():674094. PubMed ID: 34917121
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathological features and prognosis of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer].
    Wang Y; Zhang S; Zhang H; Liang L; Xu L; Cheng YJ; Duan XN; Liu YH; Li T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):853-862. PubMed ID: 36241228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of lymph node-negative breast cancer: Association with clinicopathological factors and tumor associated gene expression.
    He J; Wang H; Ma F; Feng F; Lin C; Qian H
    Oncol Lett; 2014 Oct; 8(4):1717-1724. PubMed ID: 25202398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lack of progesterone receptor expression predicts poor prognosis in patients with operable ER-positive invasive breast cancer].
    Ma RM; Chen CZ; Lin CQ; Zhang W; Guo GL
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):687-92. PubMed ID: 27647402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance of Hormone Receptor Status and BRCA1/2 Mutation Among Women With Synchronous Bilateral Breast Cancer.
    Huang L; Liu Q; Lang GT; Cao AY; Shao ZM
    Front Oncol; 2020; 10():27. PubMed ID: 32117708
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence, treatment patterns, and prognosis of low estrogen receptor-positive (1% to 10%) breast cancer: a single institution's experience in Korea.
    Park YH; Karantza V; Calhoun SR; Park S; Lee S; Kim JY; Yu JH; Kim SW; Lee JE; Nam SJ; Aktan G; Marsico M
    Breast Cancer Res Treat; 2021 Oct; 189(3):653-663. PubMed ID: 34487293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive Factors for BRCA1 and BRCA2 Genetic Testing in an Asian Clinic-Based Population.
    Wong ES; Shekar S; Chan CH; Hong LZ; Poon SY; Silla T; Lin C; Kumar V; Davila S; Voorhoeve M; Thike AA; Ho GH; Yap YS; Tan PH; Tan MH; Ang P; Lee AS
    PLoS One; 2015; 10(7):e0134408. PubMed ID: 26221963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of extranodal extension in sentinel lymph node positive breast cancer.
    Yang X; Ma X; Yang W; Shui R
    Sci Rep; 2020 Sep; 10(1):14684. PubMed ID: 32895434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Eleven Novel
    Hamdi Y; Mighri N; Boujemaa M; Mejri N; Ben Nasr S; Ben Rekaya M; Messaoud O; Bouaziz H; Berrazega Y; Rachdi H; Jaidane O; Daoud N; Zribi A; Ayari J; El Benna H; Labidi S; Ben Hassouna J; Haddaoui A; Rahal K; Benna F; Mrad R; Ben Ahmed S; Boussen H; Boubaker S; Abdelhak S
    Front Oncol; 2021; 11():674965. PubMed ID: 34490083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
    Sanford RA; Song J; Gutierrez-Barrera AM; Profato J; Woodson A; Litton JK; Bedrosian I; Albarracin CT; Valero V; Arun B
    Cancer; 2015 Oct; 121(19):3422-7. PubMed ID: 26280679
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.